Intragenomic Heterogeneity of DNA Damage Formation and Repair: A Review of Cellular Responses to Covalent Drug DNA Interaction

References

• Pullman A., Pullman B. Molecular electrostatic potential of the nucleic acids. Q. Rev. Biophys 1981; 14: 289
   PubMed Web of Science ®Google Scholar
• Bohr V. A., Phillips D. H., Hanawalt P. C. Heterogeneous DNA damage and repair in the mammalian genome. Cancer Res. 1987; 47: 6426
   PubMed Web of Science ®Google Scholar
• Gralla J. D., Sasse-Dwight S., Poljak L. G. Formation of blocking lesions at identical DNA sequences by the nitrosourea and platinum classes of anticancer drugs. Cancer Red. 1987; 47: 5092
   PubMed Web of Science ®Google Scholar
• Ponti M., Forrow S. M., Souhami R. L., D'Incalci M., Hartley J. A. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucl. Acids Res. 1991; 19: 2929
   PubMed Web of Science ®Google Scholar
• Pieper R. O., Futscher B. W., Erickson L. C. Transcription-terminating lesions induced by bifunctional alkylating agents in vitro. Carcinogenesis 1989; 10: 1307
   PubMed Web of Science ®Google Scholar
• Gray P. J., Cullinane C., Phillips D. R. In vitro transcription analysis of DNA alkylation by nitrogen mustard. Biochemistry 1991; 30: 8036
   Google Scholar
• Broggini M., Ponti M., Ottolenghi S., D'Incalci M., Mongelli N., Mantovani R. Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucl. Acids Res. 1989; 17: 1051
   PubMed Web of Science ®Google Scholar
• Capranico G., Kohn K. W., Pommier Y. Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin. Nucl. Acids Res. 1990; 18: 6611
   PubMed Web of Science ®Google Scholar
• Hanawalt P. C., Sarasin A. Cancer-prone hereditary diseases with DNA processing abnormalities. Trends Genet. 1986; 124
   Google Scholar
• Wei Q., Matanoski G. M., Farmer E. R., Hedayati M. A., Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 1614
   PubMed Web of Science ®Google Scholar
• Kovacs E., Langemann H., Ludwig H. Do chemo- and radiotherapy affect the DNA repair ability of lymphocytes?. Arch. Gynecol. Onstet. 1992; 251: 121
   Google Scholar
• Bohr V., Køber L. DNA repair in lymphocytes from patients with secondary leukemia as measured by strand rejoining and unscheduled DNA synthesis. Mutat. Res. 1985; 146: 219
   PubMedGoogle Scholar
• Skovsgaard T., Nielsen D., Maare C., Wassermann K. Cellular resistance to cancer chemotherapy. Int. Rev. Cyot., in press
   Google Scholar
• Watson J. D., Crick F. H. C. Genetical implications of the structure of deoxyribonucleic acid. Nature (London) 1953; 171: 964
   PubMed Web of Science ®Google Scholar
• Noll M. Subunit structure of chromatin. Nature (London) 1974; 251: 249
   PubMed Web of Science ®Google Scholar
• Thoma F., Koller T., Klug A. Involvement of histone H1 in the organization of the nucleosome and of the salt-dependent superstructures of chromation. J. Cell Biol. 1979; 83: 403
   PubMed Web of Science ®Google Scholar
• Thomas J. O., Butler P. J. G. Size-dependence of a stable higher-order structure of chromatin. J. Mol. Biol. 1980; 144: 89
   PubMed Web of Science ®Google Scholar
• Paulson J. R., Laemmli U. K. The structure of histone-depleted metaphase chromosomes. Cell 1977; 12: 817
   PubMed Web of Science ®Google Scholar
• Gasser S. M., Laemmli U. K. Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster. Cell 1986; 46: 521
   PubMedGoogle Scholar
• Igo-Kemenes T., Horz W., Zachau H. G. Chromatin. Annu. Rev. Biochem. 1982; 51: 89
   PubMed Web of Science ®Google Scholar
• Earnshaw W. C., Halligan B., Cooke C. A., Heck M. M., Liu L. F. Topoisomerase II is a structural component of mitotic chromosome scaffolds. J. Cell Biol. 1985; 100: 1706
   PubMed Web of Science ®Google Scholar
• Liu L. F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 1989; 58: 351
   PubMed Web of Science ®Google Scholar
• Muller M. T., Pfund W. P., Mehta V. B., Trask D. K. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO J. 1985; 4: 1237
   PubMedGoogle Scholar
• Rose K. M., Szopa J., Han F. S., Cheng Y. C., Richter A., Scheer U. Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription. Chromosoma 1988; 96: 411
   PubMed Web of Science ®Google Scholar
• Fleischmann G., Pflugfelder G., Steiner E. K., Javaherian K., Howard G. C., Wang J. C., Elgin S. C. Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome. Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 6958
   PubMedGoogle Scholar
• Culotta V., Sollner-Webb B. Sites of topoisomerase I action on X. laevis ribosomal chromatin: transcriptionally active rDNA has an approximately 200 bp repeating structure. Cell 1988; 52: 585
   PubMed Web of Science ®Google Scholar
• Tsao Y. P., Wu H. Y., Liu L. F. Transcription-driven supercoiling of DNA: direct biochemical evidence from in vitro studies. Cell 1989; 56: 111
   PubMed Web of Science ®Google Scholar
• Cook P. R. The nucleoskeleton and the topology of transcription. Eur. J. Biochem. 1989; 185: 487
   PubMedGoogle Scholar
• Dijkwel P. A., Mullenders L. H. F., Wanka F. Analysis of the attachment of replicating DNA to a nuclear matrix in mammalian interphase nuclei. Nucl. Acids Res. 1979; 6: 219
   PubMedGoogle Scholar
• Dworetzky S. I., Wright K. L., Fey E. G., Penman S., Lian J. B., Stein J. L. Sequence-specific DNA-binding proteins are components of a nuclear matrix-attachment site. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 4178
   PubMed Web of Science ®Google Scholar
• Getzenberg R. H., Pienta K. J., Ward W. S., Coffey D. S. Nuclear structure and the three-dimensional organization of DNA. J. Cell. Biochem. 1991; 47: 289
   PubMedGoogle Scholar
• Ciejek E. M., Tsai M. J., O'Malley B W. Actively transcribed genes are associated with the nuclear matrix. Nature (London) 1983; 306: 607
   PubMed Web of Science ®Google Scholar
• Gasser S. M., Laemmli U. K. The organisation of chromatin loops: characterization of a scaffold attachment site. EMBO J. 1986; 5: 511
   PubMed Web of Science ®Google Scholar
• Gross D. S., Garrard W. T. Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 1988; 57: 159
   PubMed Web of Science ®Google Scholar
• Workman J. L., Abmayr S. M., Cromlish W. A., Roeder R. G. Transcriptional regulation by the immediate early protein of pseudorabies virus during in vitro nucleosome assembly. Cell 1988; 55: 211
   PubMedGoogle Scholar
• Workman J. L., Kingston R. E. Nucleosome core displacement in vitro via a metastable transcription factor-nucleosome complex. Science 1992; 258: 1780
   PubMedGoogle Scholar
• Reeves R. Transcriptionally active chromatin. Biochim. Biophys. Acta 1984; 782: 343
   PubMed Web of Science ®Google Scholar
• Anderson S., Bankier A. T., Barrel B. G., deBruijn M. H. L., Coulson A. R., Drouin J., Eperon I. C., Nierlich D. P., Roe B. A., Sanger F., Schreier P. H., Smith A. J. H., Staden R., Young I. G. Sequence and organization of the human mitochondrial genome. Nature (London) 1981; 290: 457
   PubMed Web of Science ®Google Scholar
• Clayton D. A. Transcription of the mammalian mitochondrial genome. Annu. Rev. Biochem. 1984; 53: 573
   PubMed Web of Science ®Google Scholar
• Acton E. M., Tong G. L., Mosher C. W., Wolgemuth R. L. Intensely potent morpholinyl anthracyclines. J. Med. Chem. 1984; 27: 638
   PubMed Web of Science ®Google Scholar
• Sikic B. I., Ehsan M. N., Harker W. G., Friend N. F., Brown B. W., Newman R. A., Hacker R. A., Acton E. M. Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog. Science 1985; 228: 1544
   PubMedGoogle Scholar
• Johnston J. B., Habernicht B., Acton E. M., Glazer R. I. 3′-(3-Cyano-4-morpholinyl)-3′-deaminoadriamycin: a new anthracycline with intense potency. Biochem. Pharmacol. 1983; 32: 3255
   PubMedGoogle Scholar
• Streeter D. G., Taylor D. L., Acton E. M., Peters J. H. Comparative cytotoxicities of various morpholinyl anthracyclines. Cancer Chemother. Pharmacol. 1985; 14: 160
   PubMed Web of Science ®Google Scholar
• Wassermann K., Zwelling L. A., Mullis T. D., Silberman L. E., Andersson B. S., Bakic M., Acton E. M., Newman R. A. Effects of 3′-deamino-3′-(3-cyano-4-morpholinyl)doxorubicinand doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro. Cancer Res. 1986; 46: 4041
   PubMed Web of Science ®Google Scholar
• Scudder S. A., Brown J. M., Sikic B. I. DNA cross-linking and cytotoxicity of the alkylating cyanomorpholino derivative of doxorubicin in multidrug-resistant cells. J. Natl. Cancer Inst. 1988; 80: 1294
   Google Scholar
• Krowicki K., Balzarini J., De Clercq R., Newman R. A., Lown J. W. Novel DNA groove binding alkylators: design, synthesis, and biological evaluation. J. Med. Chem. 1988; 31: 341
   PubMed Web of Science ®Google Scholar
• Broggini M., Erba E., Ponti M., Ballinari D., Geroni C., Spreafico F., D'Incalci M. Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Res. 1991; 51: 199
   PubMed Web of Science ®Google Scholar
• Skovsgaard T. Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells. Biochem. Pharmacol. 1978; 27: 1221
   PubMed Web of Science ®Google Scholar
• Begleiter A, Johnston J. B. DNA crosslinking by3′-(3-cyano-4-morpholinyl)-3′-deaminoadriamycin in HT-29 human colon carcinoma cells in vitro. Biochem. Biophys. Res. Commun. 1985; 131: 336
   Google Scholar
• Streeter D. G., Johl J. S., Gordon G. R., Peters J. H. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and resistant P388 cells. Cancer Chemother. Pharmacol. 1986; 16: 247
   Google Scholar
• Johnston J. B., Pugh L., Begleiter A. Cellular pharmacology of 3′-(3-cyano-4-morpholinyl)-3′-deaminoadriamycin and structural analogues in human colon carcinoma HT-29 cells in vitro. Cancer Res. 1987; 47: 4076
   Google Scholar
• Begleiter A., Jesson M. I., Johnston J. B. Uptake and binding of 3′-(3-cyano-4-morpholinyl)-3′-deaminoadriamycin and 3′-(4-morpholinyl)-3′-deaminoadriamycin in L5178Y lymphoblasts in vitro. Cancer Commun. 1990; 2: 7
   Google Scholar
• Lown J. E., Joshua A. V., Lee J. S. Molecular mechanisms of binding and single-strand scission of deoxyribonucleic acid by the antitumor antibiotic saframycins A and C. Biochemistry 1982; 21: 419
   PubMed Web of Science ®Google Scholar
• Westendorf J., Groth G., Steinheider G., Marquardt H. Formation of DNA-adducts and induction of DNA-crosslinks and chromosomal aberrations by the new potent anthracycline antitumor antibiotics: morpholinyldaunomycin, cyanomorpholinodaunomycin and cyanomorpholinoadriamycin. Cell Biol. Toxicol. 1985; 1: 87
   Google Scholar
• Jesson M. I., Johnston J. B., Anhalt C. D., Begleiter A. Effects of 3′-(3-cyano-4-morpholinyl)-3′-deaminoadriamycin and structural analogues on DNA in HT-29 human colon carcinoma cells. Cancer Res. 1987; 47: 5935
   PubMedGoogle Scholar
• Jesson M. I., Johnston J. B., Robotham E., Begleiter A. Characterization of the DNA-DNA cross-linking activity of 3′-(3-cyano-4-morpholinyl)-3′-deaminoadriamycin. Cancer Res. 1989; 49: 7031
   PubMedGoogle Scholar
• Wassermann K., Markovits J., Jaxel C., Capranico G., Kohn K. W., Pommier Y. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerase I and II. Mol. Pharmacol. 1990; 38: 38
   PubMed Web of Science ®Google Scholar
• Acton E. M., Wassermann K., Newman R. A. Morpholinyl anthracyclines. Anthracycline and Anthracenedione-Based Anticancer Agents, J. W. Lown. Elsevier, New York 1988; 55
   Google Scholar
• Lau D. H. M., Lewis A. D., Sikic B. I. Association of DNA crosslinking with potentiation of the morpholino derivative of doxorubicin by human liver microsomes. J. Natl. Cancer Inst. 1989; 81: 1034
   PubMed Web of Science ®Google Scholar
• Lewis A. D., Lau D. H. M., Duran G. E., Wolf C. R., Sikic B. I. Role of cytochrome P-450 from the human CYP3A gene family in the potentiation of morpholino doxorubicin by human liver microsomes. Cancer Res. 1992; 52: 4379
   PubMed Web of Science ®Google Scholar
• Colvin M. The alkylating agents. Pharmacologic Principles of Cancer Treatment, B. Chabner. W.B. Saunders, Philadelphia 1982; 276
   Google Scholar
• Prokopczyk B., Bertinato P., Hoffmann D. Cyanoethylation of DNA in vivo by 3-(methylnitro-samino)propionitrile and Areca-derived carcinogen. Cancer Res. 1988; 48: 6780
   PubMed Web of Science ®Google Scholar
• Overton M., Hickman J. A., Threadgill M. D., Vaughan K., Gescher A. The generation of potentially toxic, reactive iminium ions from the oxidative metabolism of xenobiotic N-alkyl compounds. Biochem. Pharmacol. 1985; 34: 2055
   PubMed Web of Science ®Google Scholar
• Ho B., Castagnoli N. Trapping of metabolically generated electrophilic species with cyanide ion: metabolism of 1-benzylpyrrolidine. J. Med. Chem. 1980; 23: 133
   PubMed Web of Science ®Google Scholar
• Weissman J., Trevor A., Chiba K., Peterson L. A., Caldera P., Castagnoli N., Baillie T. Metabolism of the nigrostriatal toxin l-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine by liver homogenate fractions. J. Med. Chem. 1985; 28: 997
   PubMed Web of Science ®Google Scholar
• Cullinane C., Phillips D. R. The DNA sequence specificity of cyanomorpholinoadriamycin. FEBS Lett. 1991; 293: 195
   Google Scholar
• White R. J., Phillips D. R. Transcriptional analysis of multisites drug-DNA dissociation kinetics: delayed termination of transcription by actinomycin D. Biochemistry 1988; 27: 9122
   Google Scholar
• Kohn K. W., Hartley J. A., Mattes W. B. Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards. Nucl. Acids Res. 1987; 15: 10531
   PubMed Web of Science ®Google Scholar
• Mattes W. B., Hartley J. A., Kohn K. W. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucl. Acids Res. 1986; 14: 2971
   PubMed Web of Science ®Google Scholar
• Hartley J. A., Bingham J. P., Souhami R. L. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells. Nucl. Acids Res. 1992; 20: 3175
   PubMed Web of Science ®Google Scholar
• Kohn K. W., Spears C. L., Doty P. Interstrand crosslinking of DNA by nitrogen mustard. J. Mol. Biol. 1966; 19: 266
   PubMed Web of Science ®Google Scholar
• Lawley P. D., Brookes P. Interstrand cross-linking of DNA by difunctional alkylating agents. J. Mol. Biol. 1967; 25: 143
   PubMed Web of Science ®Google Scholar
• Walker I. G. Intrastrand bifunctional alkylation of DNA in mammalian cells treated with mustard gas. Can. J. Biochem. 1971; 49: 332
   PubMedGoogle Scholar
• O'Connor P. M., Kohn K. W. Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards. Cancer Commun. 1990; 2: 387
   PubMedGoogle Scholar
• Thomas C. B., Kohn K. W., Bonner W. B. Characterization of DNA-protein cross-links formed by treatment of L1210 cells and nuclei withbis (2-chloroethyl)methylamine (nitrogen mustard). Biochemistry 1978; 17: 3954
   PubMedGoogle Scholar
• Hartley J. A., Forrow S. M., Souhami R. L. Effect of ionic strength and cationic DNA affinity binders on the DNA sequence alkylation of guanine N7-positions by nitrogen mustards. Biochemistry 1990; 29: 2985
   PubMed Web of Science ®Google Scholar
• Hartley J. A., Gibson N. W., Kohn K. W., Mattes W. B. DNA sequence selectivity of guanine-N7 alkylation by three antitumor chlorethylating agents. Cancer Res. 1986; 46: 1943
   PubMed Web of Science ®Google Scholar
• Grunberg S. M., Haseltine W. A. Use of an indicator sequence of human DNA to study DNA damage by methylbis(2-chloroethyl)amine. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 6546
   PubMed Web of Science ®Google Scholar
• Zerial M., Salinas J., Filipski J., Bernardi G. Gene distribution and nucleotide sequence organization in the human genome. Eur. J. Biochem. 1986; 160: 479
   Google Scholar
• Mattes W. B., Hartley J. A., Kohn K. W., Matheson D. W. GC-rich regions in genomes as targets for DNA alkylation. Carcinogenesis 1988; 9: 2065
   PubMed Web of Science ®Google Scholar
• Mitchell P. J., Carothers A. M., Han J. H., Harding J. D., Kas E., Venolia L., Chasin L. A. Multiple transcription start sites, DNase I-hypersensitive sites, and an opposite-strand exon in the 5′ region of the CHOdhfr gene. Mol. Cell. Biol. 1986; 6: 425
   PubMedGoogle Scholar
• Gonzales I. L., Gorski J. L., Campen T. J., Dorney D. J., Erickson J. M., Sylvester J. E., Schmickel R. D. Variation among human 28S ribosomal RNA genes. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 7666
   PubMedGoogle Scholar
• Gonzales I. L., Sylvester J. E., Schmickel R. D. Human 28S ribosomal RNA sequence heterogeneity. Nucl. Acids Res. 1988; 16: 10213
   Google Scholar
• Ryan A. J., Billett M. A., O'Connor P. J. Selective repair of methylated purines in regions of chromatin DNA. Carcinogenesis 1986; 7: 1497
   PubMedGoogle Scholar
• Durante M., Geri C., Bonatti S., Parenti R. Non-random alkylation of DNA sequences induced in vivo by chemical mutagens. Carcinogenesis 1989; 10: 1357
   Google Scholar
• Chiu S. M., Oleinick N. L., Friedman L. R., Stambrook P. J. Hypersensitivity of DNA in transcriptionally active chromatin to ionizing radiation. Biochim. Biophys. Acta 1982; 699: 15
   PubMed Web of Science ®Google Scholar
• Beckman R. P., Agostino M. J., Mc Hugh M. M., Sigmund R. D., Beerman T. A. Assessment of preferential cleavage of an actively transcribed retroviral hybrid gene in murine cells by deoxyribo-nuclease I, bleomycin, neocarzinostatin, or ionizing radiation. Biochemistry 1987; 26: 5409
   Google Scholar
• Bartlett J. D., Scicchitano D. A., Robison S. H. Two expressed human genes sustain slightly more DNA damage after alkylating agent treatment than an inactive gene. Mutat. Res. 1991; 255: 247
   Google Scholar
• Wassermann K., Kohn K. W., Bohr V. A. Heterogeneity of nitrogen mustard-induced DNA damage and repair at the level of the gene in Chinese hamster ovary cells. J. Biol. Chem. 1990; 265: 13906
   PubMedGoogle Scholar
• Wassermann K., Pirsel M., Bohr V. A. Overexpression of metallothionein in Chinese hamster ovary cells and its effect on nitrogen mustard-induced cytotoxicity: role of gene-specific damage and repair. Cancer Res. 1992; 52: 6853
   Google Scholar
• Larminat F., Zhen W., Bohr V. A. Gene-specific DNA repair of interstrand cross-links induced by chemotherapeutic agents can be preferential. J. Biol. Chem. 1993; 268: 2649
   Google Scholar
• May A., Nairn S., Okumoto D. S., Wassermann K., Stevnser T., Jones J. C., Bohr V. A. Repair of individual DNA strands in the hamster dihydrofolate reductase gene after treatment with ultraviolet light, alkylating agents, and cisplatin. J. Biol. Chem. 1993; 268: 1650
   PubMedGoogle Scholar
• Islas A. L., Vos J. M. H., Hanawalt P. C. Differential introduction and repair of psoralen photoadducts to DNA in specific human genes. Cancer Res. 1991; 51: 2867
   PubMedGoogle Scholar
• Futcher B. W., Pieper R. O., Dalton W. S., Erickson L. C. Gene-specific DNA interstrand crosslinks produced by nitrogen mustard in the human tumor cell line colo320HSR. Cell Growth Diff. 1992; 3: 217
   Google Scholar
• Milligan J. R., Archer M. C. Alkylation of individual genes in rat liver by the carcinogen N-nitrosodimethylamine. Biochem. Biophys. Res. Commun. 1988; 155: 14
   Google Scholar
• Scicchitano D. A., Hanawalt P. C. Repair of N-methylpurines in specific DNA sequences in Chinese hamster ovary cells: absence of strand specificity in the dihydrofolate reductase gene. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 3050
   PubMed Web of Science ®Google Scholar
• LeDoux S. P., Patton N. J., Nelson J. W., Bohr V. A., Wilson G. L. Preferential DNA repair of alkali-labile sites within the active insulin gene. J. Biol. Chem. 1990; 265: 14875
   PubMedGoogle Scholar
• Nose K., Nikaido O. Transcriptionally active and inactive genes are similarly modified by chemical carcinogens or X-ray in normal fibroblasts. Biochim. Biophys. Acta 1984; 781: 273
   PubMedGoogle Scholar
• Mosher C. W., Wu H. Y., Fujiwara A. N., Acton E. M. Enhanced antitumor properties of 3′-(4-morpholinyl) and 3′-(4-methoxy-l-piperidinyl) derivatives of 3′-deaminodaunorubicin. J. Med. Chem. 1982; 25: 18
   PubMedGoogle Scholar
• Acton E. M. N-alkylation of anthracyclines. Anthracyclines. Current Status and New Developments, S. T. Crooke, S. D. Reich. Academic Press, New York 1980; 15
   Google Scholar
• Johnston J. B., Glazer R. L. Pharmacological studies of 3′-(4-morpholinyl)-3′-deaminodaunorubicin in human colon carcinoma cells in vitro. Cancer Res. 1983; 43: 1044
   Google Scholar
• Johnston J. B., Glazer R. I. Cellular pharmacology of 3′-(4-morpholinyl) and 3′-(4-methoxy-l-piperidinyl) derivatives of 3′-deaminodaunorubicin in human colon carcinoma cells in vitro. Cancer Res. 1983; 43: 1606
   Google Scholar
• Scheer U., Trendelenburg M. F., Franke W. W. Effects of actinomycin D on the association of newly formed ribonucleoproteins with the cistrons of ribosomal RNA in triturus oocytes. J. Cell. Biol. 1975; 65: 163
   Google Scholar
• Scheer U., Rose K. M. Localization of RNA polymerase I in interphase cells and mitotic chromosomes by light and electron microscopic immunocytochemistry. Proc. Natl. Acad. Aci. U.S.A. 1984; 81: 1431
   PubMed Web of Science ®Google Scholar
• Wassermann K., Newman R. A., Davis F. M., Muliins T. D., Rose K. M. Selective inhibition of human ribosomal gene transcription by the morpholinyl anthracyclines cyanomoipholinyl- and morpholinyldoxorubicin. Cancer Res. 1988; 48: 4102
   Google Scholar
• Wassermann K., Damgaard J. Ongoing activity of RNA polymerase II confers preferential repair of nitrogen mustard-induced N-alkylpurines in the hamster dihydrofolate reductase gene. Cancer Res. 1994; 54: 175
   Google Scholar
• Stevnsner T., May A., Petersen L. N., Larminat F., Pirsel M., Bohr V. A. Repair of ribosomal RNA genes in hamster cells after UV irradiation, or treatment with cisplatin or alkylating agents. Carcinogenesis 1993; 14: 1591
   Google Scholar
• Fabbri S., Prontera C., Broggini M., D'Incalci M. Differential inhibition of the DNA binding of transcription factors NFxB and OTF-1 by nitrogen mustard and quinacrine mustard: transcriptional implications. Carcinogenesis 1993; 14: 1963
   Google Scholar
• Saubier W., Hercules K. A. Gene and transcription mapping by radiation effects. Annu. Rev. Genet. 1978; 12: 329
   Google Scholar
• Selby C. P., Sancar A. Transcription preferentially inhibits nucleotide excision repair of the template DNA strand in vitro. J. Biol. Chem. 1990; 265: 21330
   PubMed Web of Science ®Google Scholar
• Shi Y. B., Gamper H., Hearst J. E. The effects of covalent additions of psoralen on transcription byE. coli RNA polymerase. Nucl. Acids Res. 1987; 15: 6843
   PubMedGoogle Scholar
• Shi Y. B., Gamper H., Van Houten B., Hearst J. E. Interaction ofEscherichia coli RNA polymerase with DNA in an elongation complex arrested at a specific psoralen crosslink site. J. Mol. Biol. 1988; 199: 277
   PubMedGoogle Scholar
• Yu F. L. Mechanism of aflatoxin B1 inhibition of rat hepatic nuclear RNA synthesis. J. Biol. Chem. 1977; 252: 3245
   PubMed Web of Science ®Google Scholar
• Pommier Y., Kohn K. Topoisomerase II inhibition by antitumor intercalators and dimethyl-epipodophyllotoxins. Development in Cancer Chemotherapy, R. I. Glazer. CRC Press, Boca Raton, FL 1989; 175
   Google Scholar
• Quigley G. J., Wang A. H., Ughetto G., Van der Marel G., Van Boom J. H., Rich A. Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG). Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 7204
   PubMed Web of Science ®Google Scholar
• Ross W. E., Glaubiger D. L., Kohn K. W. Protein-associated DNA breaks in cells treated with adriamycin or ellipticine. Biochim. Biophys. Acta 1978; 519: 23
   PubMed Web of Science ®Google Scholar
• Tewey K. M., Rowe T. C., Yang L., Halligan B. D., Liu L. F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase n. Science 1984; 226: 466
   PubMed Web of Science ®Google Scholar
• Wu H. Y., Shyy S. H., Wang J. C., Liu L. F. Transcription generates positively and negatively supercoiled domains in the template. Cell 1988; 53: 433
   PubMed Web of Science ®Google Scholar
• Bonven B. J., Gocke E., Westergaard O. A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin. Cell 1985; 41: 541
   PubMed Web of Science ®Google Scholar
• Zhang H., Wang J. C., Liu L. F. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 1060
   PubMed Web of Science ®Google Scholar
• Ewig R. A. G., Kohn K. W. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1, 3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas. Cancer Res. 1977; 37: 2114
   PubMed Web of Science ®Google Scholar
• O'Connor P. M., Wassermann K., Sarang M., Magrath I., Bohr V. A., Kohn K. W. Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard. Cancer Res. 1991; 51: 6550
   PubMed Web of Science ®Google Scholar
• Herbert G. B., Erickson L. C. Nitrogen mustard induces apoptosis in the Colo320HSR cell line containing an amplified c-myc oncogene. Proc. Am. Assoc. Cancer Res. 1993; 34: 390
   Google Scholar
• Boerrigter M. E. T.I., Vijg J. Induction and disappearance of DNA single-strand breaks in human B and T lymphocytes after exposure to ethyl-nitrosourea. Mutat. Res. 1991; 255: 49
   PubMed Web of Science ®Google Scholar
• Lau D. H. M., Ross K. L., Sikic B. I. Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyano-morpholinio doxorubicin. Cancer Res. 1990; 50: 4056
   PubMed Web of Science ®Google Scholar
• Zwelling L. A., Altschuler E., Cherif A., Farquhar D. N-(5, 5-Diacetoxypentyl)doxorubicin: a novel anthracycline producing DNA interstrand cross-linking and rapid endonucleolytic cleavage in human leukemia cells. Cancer Res. 1991; 51: 6704
   PubMed Web of Science ®Google Scholar
• Ciarrocchi G., Lestingi M., Fontana M., Spadari S., Montecucco A. Correlation between anthracycline structure and human DNA ligase inhibition. Biochem. J. 1991; 279: 141
   Google Scholar
• Kanter P. M., Schwartz H. S. Post-repair DNA damage in X-irradiated cultured human tumour cells. Int. J. Radiat. Biol. 1980; 38: 483
   Web of Science ®Google Scholar
• Wassermann K., Damgaard J., Olsen L. S. Induction of apoptosis in Chinese hamster ovary cells by α-amanitin. Proc. Am. Assoc. Cancer Res. 1993; 34: 435
   Google Scholar
• Tobey R. A. Different drugs arrest cells at a number of distinct stages in G2. Nature (London) 1975; 254: 245
   PubMed Web of Science ®Google Scholar
• Rao P. N. The molecular basis of drug-induced G2 arrest in mammalian cells. Mol. Cell. Biochem. 1980; 29: 47
   PubMed Web of Science ®Google Scholar
• Konopa J. G2 block induced by DNA crosslinking agents and its possible consequences. Biochem. Pharmacol. 1988; 37: 2303
   PubMed Web of Science ®Google Scholar
• Hartwell L. H., Weinert T. A. Checkpoints: control that ensures the order of cell cycle events. Science 1989; 246: 629
   PubMed Web of Science ®Google Scholar
• Sorenson C. M., Eastman A. Mechanism of cis-diaminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and double-strand breaks. Cancer Res. 1988; 48: 4484
   PubMed Web of Science ®Google Scholar
• Fernberg J. O., Lewensohn R., Skog S. Cell cycle arrest and DNA damage after melphalan treatment of the human myeloma cell line RPMI 8226. Eur. J. Haematol. 1991; 47: 161
   Google Scholar
• O'Connor P. M., Ferris D. K., White G. A., Pines J., Hunter T., Longo D. L., Kohn K. W. Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Diff. 1992; 3: 43
   PubMedGoogle Scholar
• Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991; 51: 6304
   PubMed Web of Science ®Google Scholar
• Kastan M. B., Zhan Q., El-Deiry W. S., Carrier F., Jacks T., Walsh W. V., Plunkett B. S., Vogelstein B., Fornace A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587
   PubMed Web of Science ®Google Scholar
• O'Connor P. M., Jackman J., Jondle D., Bhatia K., Magrath I., Kohn K. W. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 1993; 53: 4776
   PubMed Web of Science ®Google Scholar
• Jacobs A., Bopp A., Hagen U. In vitro repair of single-strand breaks in irradiated DNA by polynucleotide ligase. Int. J. Radiat. Biol. 1972; 22: 431
   Web of Science ®Google Scholar
• Francis A. A., Snyder R. D., Dunn W. C., Regan J. D. Classification of chemical agents as to their ability to induce long- or short-patch DNA repair in human cells. Mutat. Res. 1981; 83: 159
   PubMed Web of Science ®Google Scholar
• Huang J. C., Svoboda D. L., Reardon J. T., Sancar A. Human nucleotide excision nuclease removes thymine dimers from DNA by incising the 22nd phosphodiester bond 5′ and the 6th phospho-diester bond 3′ to the photodimer. Proc. Natl. Acad. Sci. USA 1992; 89: 3664
   PubMed Web of Science ®Google Scholar
• Di Giuseppe J. A., Dresler S. L. Bleomycin-induced DNA repair synthesis in permeable human fibroblasts: mediation of long-patch and short-patch repair by distinct DNA polymerases. Biochemistry 1989; 28: 9515
   Google Scholar
• Prakash L., Johnson R., Sung P., Prakash S. Genes and proteins of saccharomyces cerevisiae that function in postreplication repair. DNA Repair Mechanisms, V. A. Bohr, K. Wassermann, K. H. Kraemer. Munksgaard, Copenhagen 1993; 374
   Google Scholar
• Ganesan A. K., Spivak G., Hanawalt P. C. Expression of DNA repair genes in mammalian cells. Manipulation and Expression of Genes in Eukaryotes, P. Nagley, A. W. Linnane, W. J. Peacock, J. A. Pateman. Academic Press, Sydney 1983; 45
   Google Scholar
• Zolan M. E., Cortopassi G. A., Smith C. A., Hanawalt P. C. Deficient repair of chemical ad-ducts in α DNA of monkey cells. Cell 1982; 28: 613
   PubMedGoogle Scholar
• Mullenders L. H. F., van Kesteren A. C., Bussmann C. J. M., van Zeeland A. A., Natarajan A. T. Preferential repair of nuclear matrix associated DNA in xeroderma pigmentosum complementation group. C, Mutat. Res. 1984; 141: 75
   PubMedGoogle Scholar
• Mullenders L. H. F., van Kesteren van Leeuwen A. C., van Zeeland A. A., Natarajan A. T. Nuclear matrix associated DNA is preferentially repaired in normal human fibroblasts, exposed to a low dose of ultraviolet light but not in Cockayne's syndrome fibroblasts. Nucl. Acids Res. 1988; 16: 10607
   PubMed Web of Science ®Google Scholar
• Mayne L. V., Lehmann A. R. Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne's syndrome and xerodermia pigmentosum. Cancer Res. 1982; 42: 1473
   PubMed Web of Science ®Google Scholar
• Bohr V. A., Smith C. A., Okumoto D. S., Hanawalt P. C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 1985; 40: 359
   PubMed Web of Science ®Google Scholar
• Madhani H. D., Bohr V. A., Hanawalt P. C. Differential DNA repair in transcriptionally active and inactive proto-oncogenes: c-abl and c-mos. Cell 1986; 45: 417
   PubMed Web of Science ®Google Scholar
• Vos J. M. H., Hanawalt P. C. Processing of psoralen adducts in an active human gene: repair and replication of DNA containing monoadducts and interstrand cross-links. Cell 1987; 50: 789
   PubMed Web of Science ®Google Scholar
• Venema J., van Hoffen A., Karcagi V., Natarajan A. T., van Zeeland A. A., Mullenders L. H. F. Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol. Cell. Biol. 1991; 11: 4128
   PubMed Web of Science ®Google Scholar
• Ganesan A. K., Smith C. A., van Zeeland A. A. Measurement of the pyrimidine dimer content of DNA in permeabilized bacterial or mammalian cells with endonuclease V of bacteriophage T4. DNA Repair. A Laboratory Manual of Research Procedures, E. C. Friedberg, P. C. Hanawalt. Marcel Dekker, New York 1981; 89
   Google Scholar
• Bohr V. A., Okumoto D. S., Hanawalt P. C. Survival of UV-irradiated mammalian cells correlates with efficient DNA repair in an essential gene. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 3830
   PubMed Web of Science ®Google Scholar
• Mellon I., Spivak G., Hanawalt P. C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 1987; 51: 241
   PubMed Web of Science ®Google Scholar
• Mellon I., Bohr V. A., Smith C. A., Hanawalt P. C. Preferential DNA repair of an active gene in human cells. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 8878
   PubMed Web of Science ®Google Scholar
• Leadon S. A., Lawrence D. A. Preferential repair of DNA damage on the transcribed strand of the human metallothionein genes requires RNA polymerase II. Mutat. Res. 1991; 255: 67
   PubMedGoogle Scholar
• Williams J. I., Friedberg E. C. Deoxyribonucleic acid excision repair in chromatin after ultraviolet irradiation of human fibroblasts in culture. Biochemistry 1979; 18: 3965
   PubMedGoogle Scholar
• Johnston R. N., Beverly S. M., Schimke R. T. Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 3711
   PubMed Web of Science ®Google Scholar
• Conrad J., Müller N., Eisenbrand G. Studies on the stability of trialkyl phosphates and di-(2′-deoxythymidine) phosphotriesters in alkaline and neutral solution. A model study for hydrolysis of phosphotriesters in DNA and on the influence of a β-hydroxyethyl ester group. Chem. Biol. Interact 1986; 60: 57
   Google Scholar
• Mattes W. B., Hartey J. A., Kohn K. W. Mechanism of DNA strand breakage by piperidine at sites of N7-alkylguanines. Biochim. Biophys. Acta 1986; 868: 71
   PubMed Web of Science ®Google Scholar
• Chun E. H. L., Gonzales L., Lewis F. S., Jones J., Rutman R. J. Differences in the in vivo alkylation and cross-linking of nitrogen mustard-sensitive and -resistant lines of Lettré-Ehrlich ascites tumors. Cancer Res. 1969; 29: 1184
   Google Scholar
• Yin L., Chun E. H., Rutman R. J. A comparison of the effects of alkylation on the DNA of sensitive and resistant Lettré-Ehrlich cells following in vivo exposure to nitrogen mustard. Biochim. Biophys. Acta 1973; 324: 472
   Google Scholar
• Coombs M. M., Livingston D. C. Reaction of apurinc acid with aldehyde reagents. Biochim. Biophys. Acta 1969; 174: 161
   PubMedGoogle Scholar
• Talpaert-Borlea M., Liuzzi M. Reaction of apurinic/apyrimidinic sites with [14C]methoxyamine. A method for the quantitative assay of AP sites in DNA. Biochim. Biophys. Acta 1983; 740: 410
   Google Scholar
• Friedberg E. C. DNA Repair. W.H. Freeman, New York 1985
   Google Scholar
• Hollander M. C., Fornace A. J. Induction of fos RNA by DNA-damaging agents. Cancer Res. 1989; 49: 1687
   PubMed Web of Science ®Google Scholar
• Mellon I., Hanawalt P. C. Induction of the Escherichia coli lactose operon selectively increases repair of its transcribed DNA strand. Nature (London) 1989; 342: 95
   PubMed Web of Science ®Google Scholar
• Selby C. P., Sancar A. Gene- and strand-specific repair in vitro: partial purification of a transcription-repair coupling factor. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 8232
   PubMed Web of Science ®Google Scholar
• Cochet-Meilhac M., Chambon P. Animal DNA-dependent RNA polymerases. Mechanism of the inhibitors of RNA polymerases B by amatoxins. Biochim. Biophys. Acta 1974; 353: 160
   PubMed Web of Science ®Google Scholar
• Vaisius A. C., Wieland T. Formation of a single phosphodiester bond by RNA polymerase B from calf thymus is not inhibited by α-amanitin. Biochemistry 1982; 21: 3097
   PubMed Web of Science ®Google Scholar
• Ljungman M., Hanawalt P. C. Localized torsional tension in the DNA of human cells. Proc. Natl. Acad Sci. U.S.A. 1992; 89: 6055
   PubMed Web of Science ®Google Scholar
• Christians F. C., Hanawalt P. C. Inhibition of transcription and strand-specific DNA repair by α-amanitin in Chinese hamster ovary cells. Mutat. Res. 1992; 274: 93
   PubMedGoogle Scholar
• Schaeffer L., Roy R., Humbert S., Moncollin V., Vermeulen W., Hoeijmarkers J. H., Chambon P., Egly J. M. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 1993; 260: 58
   PubMed Web of Science ®Google Scholar
• Selby C. P., Witkin E. M., Sancar A. Escherichia coli mfd mutant deficient in “mutation frequency decline” lacks strand-specific repair: in vitro complementation with purified coupling factor. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 11574
   PubMed Web of Science ®Google Scholar
• Selby C. P., Sancar A. Molecular mechanism of transcription-repair coupling. Science 1993; 260: 53
   PubMed Web of Science ®Google Scholar
• Griffith J. K. Coordinate expression of amplified metallothionein I and II genes in cadmium-resistant Chinese hamster cells. Mol. Cell. Biol. 1985; 5: 3525
   PubMedGoogle Scholar
• Koropatnick J., Duerksen J. D. Nuclease sensitivity of α-fetoprotein, metallothionein-1, and immunoglobulin gene sequences in mouse during development, Dev. Biol 1987; 122: 1
   Google Scholar
• Wassermann K., O'Connor P. M., Jackman J., May A., Bohr V. A. Transcription-independent repair of nitrogen mustard-induced N-alkylpurines in the c-myc gene in Burkitt's lymphoma CA46 cells. Carcinogenesis 1994; 16: 1779
   Google Scholar
• Haluska F. G., Tsujimoto Y., Croce C. M. Oncogene activation by chromosome translocation in human malignancy. Annu. Rev. Genet. 1987; 21: 321
   PubMed Web of Science ®Google Scholar
• Ar-Rushdi A., Nishikura K., Erikson J., Watt R., Rovera G., Croce C. M. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science 1983; 222: 390
   PubMed Web of Science ®Google Scholar
• Taub R., Moulding C., Battey J., Murphy W., Vasicek T., Lenoir G. M., Leder P. Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells. Cell 1984; 36: 339
   PubMed Web of Science ®Google Scholar
• Eick D., Piechaczyk M., Henglein B., Blanchard J. M., Traub B., Kofler E., Wiest S., Lenoir G. M., Bornkamm G. W. Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives. EMBO J. 1985; 4: 3717
   PubMed Web of Science ®Google Scholar
• Beecham E. J., Mushinski F., Shacter E., Potter M., Bohr V. A. DNA repair in the c-myc proto-oncogene locus: possible involvement in susceptibility or resistance to plasmacytoma induction in BALB/c mice. Mol. Cell. Biol. 1991; 11: 3095
   PubMed Web of Science ®Google Scholar
• Venema J., Bartosová Z., Natarajan A. T., van Zeeland A. A., Mullenders L. H. F. Transcription affects the rate but not the extent of repair of cyclobutane pyrimidine dimers in the human adenosine deaminase gene. J. Biol. Chem. 1992; 267: 8852
   PubMedGoogle Scholar
• Chou R. H., Churchill J. R., Flubacher M. M., Mapstone D. E., Jones J. Identification of a nuclear matrix-associated region of the c-myc protooncogene and its recognition by a nuclear protein in the human leukemia HL-60 cell line. Cancer Res. 1990; 50: 3199
   PubMedGoogle Scholar
• Siebenlist U., Hennighausen L., Battey J., Leder P. Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell 1984; 37: 381
   PubMed Web of Science ®Google Scholar
• Vos J. M. H., Wauthier E. L. Differential introduction of DNA damage and repair in mammalian genes transcribed by RNA polymerases I and II. Mol. Cell. Biol. 1991; 11: 2245
   PubMed Web of Science ®Google Scholar
• Wauthier E. L., Hanawalt P. C., Vos J. M. H. Differential repair and replication of damaged DNA in ribosomal RNA genes in different CHO cell lines. J. Cell. Biochem. 1990; 43: 173
   PubMedGoogle Scholar
• Watson J. D., Hopkins N. H., Roberts J. W., Steitz J. A., Weiner A. M. The unexpected structures of eukaryotic genomes. Molecular Biology of the Gene, J. R. Gillen. Benjamin Cummings, Menlo Park, CA 1987; 621
   Google Scholar
• LeDoux S. P., Thangada M., Bohr V. A., Wilson G. L. Heterogeneous repair of methyl-nitrosourea-induced alkali-labile sites in different DNA sequences. Cancer Res. 1991; 51: 775
   Google Scholar
• Boffa L. C., Mariani M. R., Carpaneto E. M. Effects of N-methyl-N-nitrosourea on transcriptionally active and inactive nucleosomes: macromolecular damage and DNA repair. Mol. Carcinogen. 1992; 5: 174
   Google Scholar
• Shoukry S., Anderson M. W., Glickman B. W. Use of fluorescently tagged DNA and a automated DNA sequencer for the comparison of the sequence selectivity of SN1 and SN2 alkylating agents. Carcinogenesis 1993; 14: 155
   Google Scholar
• Tomkinson A. E., Bonk R. T., Linn S. Mitochondrial endonuclease activities specific for apurinic/apyrimidinic sites in DNA from mouse cells. J. Biol. Chem. 1988; 263: 12532
   PubMedGoogle Scholar
• Domena J. D., Timmer R. T., Dicharry S. A., Mosbaugh D. W. Purification and properties of mitochondrial uracil-DNA glycosylase from rat liver. Biochemistry 1988; 27: 6742
   Google Scholar
• Tomkinson A. E., Bonk R. T., Kim J., Bartfeld N., Linn S. Mammalian mitochondrial endonuclease activities specific for ultraviolet-irradiated DNA. Nucl. Acids Res. 1990; 18: 929
   PubMed Web of Science ®Google Scholar
• Pettepher C. C., Le Doux S. P., Bohr V. A., Wilson G. L. Repair of alkali-labile sites within the mitochondrial DNA of RINr 38 cells after exposure to the nitrosourea streptozotocin. J. Biol. Chem. 1991; 266: 3113
   PubMedGoogle Scholar
• LeDoux S. P., Wilson G. L., Beecham E. J., Stevnsner T., Wassermann K., Bohr V. A. Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis 1992; 13: 1967
   PubMed Web of Science ®Google Scholar
• LeDoux S. P., Patton N. J., Avery L. J., Wilson G. L. Repair of N-methylpurines in the mitochondrial DNA of xeroderma pigmentosum complementation group D cells. Carcinogenesis 1993; 14: 913
   PubMed Web of Science ®Google Scholar
• Kuhnlein U., Penhoet E. E., Linn S. An altered apurinic DNA endonuclease activity in group A and group D xeroderma pigmentosum fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1976; 73: 1169
   PubMed Web of Science ®Google Scholar
• Staudt L. M., Singh H., Sen R., Wirth T., Sharp P. A., Baltimore D. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (London) 1986; 323: 640
   PubMed Web of Science ®Google Scholar
• Zhen W., Link C. J., O'Connor P. M., Reed E., Parker R., Howell S. B., Bohr V. A. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol. Cell. Biol. 1992; 12: 3689
   PubMedGoogle Scholar
• Vosberg H. P. DNA topoisomerases: enzymes that control DNA conformation. Current Topics in Microbiology and Immunology. Springer-Verlag, Berlin 1985; 19
   Google Scholar
• Heartlein M. W., Tsuji H., Latt S. A. 5-Bromodeoxyuridine-dependent increase in sister chromatid exchange formation in Bloom's syndrome is associated with reduction in topoisomerase II activity. Exp. Cell Res. 1987; 169: 245
   PubMed Web of Science ®Google Scholar
• Tan K. B., Mattern M. R., Boyce R. A., Schein P. S. Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 7668
   PubMed Web of Science ®Google Scholar
• Tan K. B., Mattern M. R., Boyce R. A., Hertzberg R. P., Schein P. S. Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells. Natl. Cancer Inst. Monogr. 1987; 4: 95
   Google Scholar
• Eder J. P., Teicher B. A., Holden S. A., Cathcart K. N. S., Schnipper L. E. Novobiocin enhances alkylating agents cytotoxicity and DNA interstrand crosslinks in a murine model. J. Clin. Invest. 1987; 79: 1524
   Google Scholar
• Eder J. P., Wheeler C. A., Teicher B. A., Schnipper L. E. A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity. Cancer Res. 1991; 51: 510
   PubMedGoogle Scholar
• Pedersen-Bjergaard J. Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review. Leuk. Res. 1992; 16: 61
   PubMed Web of Science ®Google Scholar
• Wang J. C. DNA topoisomerases. Annu. Rev. Biochem. 1985; 54: 665
   PubMed Web of Science ®Google Scholar
• McGregor W. G., Chen R. H., Lukash L., Maher V. M., Mc Cormick J. J. Cell cycle-dependent strand bias for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair-deficient cells. Mol. Cell. Biol. 1991; 11: 1927
   PubMed Web of Science ®Google Scholar
• Chen R. H., Maher V. M., Brouwer J., vande Putte P., Mc Cormick J. J. Preferential repair and strand-specific repair of benzo[a]pyrene diol epoxide adducts in die HPRT gene of diploid human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 5413
   PubMed Web of Science ®Google Scholar
• Knudsen L. E., Ryder L. P., Wassermann K. Induction of DNA repair synthesis in human monocytes/B-lymphocytes compared with T-lymphocytes after exposure to N-acetoxy-N-acetylamino-fluorene and dimenthyl sulfate in vitro. Carcinogenesis 1992; 13: 1285
   PubMed Web of Science ®Google Scholar
• Wassermann K., in preparation
   Google Scholar